Innohep and Hypernatraemia - a phase IV clinical study of FDA data

Summary:

Hypernatraemia is reported as a side effect among people who take Innohep (tinzaparin sodium), especially for people who are male, 60+ old, also take Asa, and have Lung neoplasm malignant.

The phase IV clinical study analyzes which people have Hypernatraemia when taking Innohep. It is created by eHealthMe based on reports of 9,220 people who have side effects when taking Innohep from the FDA, and is updated regularly.

What is Innohep?

Innohep has active ingredients of tinzaparin sodium. eHealthMe is studying from 9,243 Innohep users. Check the latest studies of Innohep.

What is Hypernatraemia?

Hypernatraemia (an abnormally high plasma concentration of sodium ions) is found to be associated with 645 drugs and 807 conditions by eHealthMe. Check the latest studies of Hypernatraemia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

9,220 people reported to have side effects when taking Innohep.
Among them, 18 people (0.2%) have Hypernatraemia.

Among these 18 people:

What is the gender of people who have Hypernatraemia when taking Innohep? *

female: 11.11 %
male: 88.89 %

What is the age of people who have Hypernatraemia when taking Innohep? *

What are other drugs people take besides Innohep? *

What are other side effects people have besides Hypernatraemia? *

Diarrhea: 10 people, 55.56%
Dehydration (dryness resulting from the removal of water): 10 people, 55.56%
Acute Kidney Failure: 8 people, 44.44%
Tachypnea: 8 people, 44.44%
Fever: 8 people, 44.44%
Nausea And Vomiting: 8 people, 44.44%
Respiratory Tract Congestion (blockage on respiratory system): 8 people, 44.44%
Febrile Bone Marrow Aplasia (bone marrow greatly decreases or stops production of blood cells): 8 people, 44.44%
Weakness: 8 people, 44.44%
Clostridium Difficile Colitis (inflammation of colon by clostridium difficile bacteria infection): 7 people, 38.89%

What are the existing conditions these people have? *

Lung Neoplasm Malignant (cancer tumour of lung): 8 people, 44.44%
Multiple Myeloma (cancer of the plasma cells): 5 people, 27.78%
Migraine (headache): 5 people, 27.78%
High Blood Pressure: 3 people, 16.67%
Pain: 2 people, 11.11%
Metastatic Carcinoma Of The Bladder (cancer types can spread to the bladder from other place): 2 people, 11.11%
Infection: 2 people, 11.11%
Burkitt Lymphoma (cancer of the lymphatic system): 2 people, 11.11%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 5.56%
High Blood Cholesterol: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Innohep and have Hypernatraemia?

- Check whether Hypernatraemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Innohep:

Innohep (9,243 reports)

Hypernatraemia treatments and more:

Hypernatraemia (6,339 reports)

Browse all side effects of Innohep:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypernatraemia:

Hypernatraemia (645 drugs)

Browse all the conditions that are associated with Hypernatraemia:

Hypernatraemia (807 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tinzaparin sodium (the active ingredients of Innohep) and Innohep (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.